Germany's BioNTech says to set up mRNA vaccine facility in Singapore
The Singapore facility is expected to be fully operational by 2023 and create more than 100 jobs by 2024.
Pfizer-BioNTech say Omicron-based Covid shots improve variant-specific response
Advisers to the US Food and Drug Administration are scheduled to meet on Tuesday to discuss whether to update Covid-19 vaccines for the fall.
Pfizer-BioNTech say booster dose increases protection vs Omicron in kids aged 5-11
Blood serum analysis of 30 paediatric participants who received a booster dose in a study showed a 36-fold increase in Omicron neutralising antibodies, the drugmakers say.
Pfizer-BioNTech seek US approval of second Covid booster for 65+
Recent studies have offered evidence that while a third mRNA vaccine dose raises antibody levels above those of the initial regimen, a fourth dose only returns individuals' levels to that same highly-elevated level.
Pfizer and BioNTech launch trial of Omicron-targeted Covid vaccine
The companies plan to study the safety and tolerability of the shots in the more than 1,400 people who will be enrolled in the trial.
BioNTech to seek approval soon for vaccine for 5-11 year olds
BioNTech, which collaborates with Pfizer, holds the lead in the race to win broad approval to vaccinate children below the age of 12 in Western countries.
No need yet to adapt Pfizer vaccine for Covid variants, says BioNTech chief
He says a decision should be made only if it is clear that the vaccine failed to work or is only offering sub-par protection against the virus.
After Covid jab, BioNTech sets sights on malaria vaccine
If successful, the vaccine could be a crucial step in the fight against the mosquito-borne disease, which kills more than 400,000 people a year.
Taiwan’s chips too vital for war, says island’s major chipmaker
Taiwan's TSMC, the world's largest contract chipmaker is at the centre of global efforts to resolve chip shortages.
Pfizer-BioNTech to seek green light for third Covid shot
The companies are also developing a Delta-specific vaccine, with clinical studies expected to begin in August.
Taiwan says China’s anger at its use of ‘country’ caused BioNTech vaccine deal collapse
China considers Taiwan its own territory and strongly objects to any reference that implies Taiwan is a separate country.
Covid jab maker BioNTech to build factory in Singapore
Construction of the manufacturing plant will start this year and the site could be operational by 2023.